InvestSMART

EMvision Medical Devices Limited (ASX:EMV)

ALERT: Price-sensitive ASX Announcement for EMV
Current share price for EMV : $1.500 -0.21 (-12.28%)+
Announcement
Release
27 May 2026 8:40AM
Price at Release
$1.710
Full Release
download
Summary
EMVision Medical Devices Limited announced successful completion of a study on the feasibility and usability of its First Responder Brain Scanner in aeromedical settings, conducted with the Royal Flying Doctor Service. The device showed positive results across various operational environments, with feedback indicating ease of use and unaffected scan quality by flight conditions. This study reduces risks related to rural and remote stroke care uses, supporting the progression towards commercial production and regulatory clearance. EMVision also received a significant milestone payment under its Australian Stroke Alliance Project Agreement.
Key Points
  • Successful completion of aeromedical feasibility and usability study for First Responder Brain Scanner.
  • Study conducted with Royal Flying Doctor Service, Australian Stroke Alliance, and South Australian Ambulance Service.
  • First Responder Brain Scanner effectively deployed in real-world aeromedical environments.
  • Positive feedback from operators, with scan data quality unaffected by flight conditions.
  • Study de-risks device's rural and remote stroke care use cases.
  • EMVision received a $400,000 milestone payment under the Australian Stroke Alliance Project Agreement.
  • The device is being evaluated in pre-hospital use cases including Mobile Stroke Unit and road ambulance settings.
  • Production equivalent units in development for data collection and regulatory clearance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.